NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: A description of the trial
The NSABP-32 trial is a randomized, phase III clinical trial to compare sentinel node (SN) resection to conventional axillary dissection in clinically node-negative breast cancer patients. The primary aims of the trial are to determine if removal of only SNs provides survival and regional control equivalent to those of axillary dissection, while diminishing the magnitude of surgically related side effects. In order to ensure consistency of the outcomes for this trial, a standardized method of SN surgery has been utilized for all cases. A secondary aim of the B32 trial is to evaluate whether patients with “occult” metastases in the SNs have worse survival. Accrual is taking place at 73 institutions in North America, and 217 surgeons are enrolling patients.
Key WordsBreast cancer Clinical trial Sentinel node Survival
- 3.Hayward JI. The Guy's Hospital trials on breast conservation. In: Silen W, ed.Conservative Management of Breast Cancer: New Surgical and Radiotherapeutic Techniques. Philadelphia: JB Lippincott, 1983:77–90.Google Scholar
- 10.Bland KI, Scott-Conner CE, Menck H, Winchester DP. Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival.J Am Coll Surg 1999;188:586–95; discussion, 595–6.PubMedCrossRefGoogle Scholar